Adam Shlomo Fisch, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gene Fusion | 4 | 2024 | 355 | 1.120 |
Why?
|
Proto-Oncogene Proteins c-myb | 1 | 2024 | 78 | 0.930 |
Why?
|
Carcinoma, Adenoid Cystic | 1 | 2024 | 262 | 0.790 |
Why?
|
Salivary Gland Neoplasms | 2 | 2024 | 304 | 0.750 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2021 | 60 | 0.730 |
Why?
|
Proto-Oncogene Proteins c-ret | 2 | 2023 | 225 | 0.700 |
Why?
|
Pathology, Molecular | 1 | 2022 | 329 | 0.650 |
Why?
|
Immunohistochemistry | 4 | 2024 | 11066 | 0.620 |
Why?
|
Sequence Analysis, RNA | 2 | 2024 | 2011 | 0.580 |
Why?
|
Gene Rearrangement | 2 | 2021 | 1125 | 0.550 |
Why?
|
Thyroid Neoplasms | 3 | 2024 | 2331 | 0.470 |
Why?
|
Brachial Artery | 1 | 2015 | 366 | 0.450 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 926 | 0.450 |
Why?
|
Ticlopidine | 3 | 2013 | 730 | 0.430 |
Why?
|
Amyloidosis | 1 | 2020 | 864 | 0.400 |
Why?
|
Nose Neoplasms | 2 | 2024 | 249 | 0.380 |
Why?
|
Aryl Hydrocarbon Hydroxylases | 1 | 2012 | 244 | 0.370 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2013 | 2746 | 0.360 |
Why?
|
Platelet Aggregation | 1 | 2012 | 771 | 0.310 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 1605 | 0.260 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2802 | 0.260 |
Why?
|
Nasal Cavity | 2 | 2024 | 304 | 0.250 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2024 | 191 | 0.220 |
Why?
|
Soft Tissue Neoplasms | 2 | 2024 | 1158 | 0.220 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 256 | 0.210 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 212 | 0.210 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2024 | 3634 | 0.210 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2023 | 58 | 0.210 |
Why?
|
Endothelial Cells | 1 | 2015 | 3550 | 0.210 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 226 | 0.190 |
Why?
|
Bone Cysts | 1 | 2021 | 48 | 0.180 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 2023 | 242 | 0.180 |
Why?
|
Algorithms | 1 | 2021 | 14023 | 0.180 |
Why?
|
Oncogene Fusion | 1 | 2020 | 81 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2021 | 314 | 0.170 |
Why?
|
Hemorrhage | 1 | 2012 | 3422 | 0.170 |
Why?
|
RNA-Binding Protein EWS | 1 | 2021 | 210 | 0.170 |
Why?
|
Sarcoma | 2 | 2021 | 1800 | 0.170 |
Why?
|
Cardiovascular Diseases | 3 | 2015 | 15513 | 0.160 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2023 | 323 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13382 | 0.160 |
Why?
|
Thrombosis | 1 | 2013 | 2944 | 0.160 |
Why?
|
Humerus | 1 | 2021 | 272 | 0.160 |
Why?
|
NFATC Transcription Factors | 1 | 2021 | 390 | 0.160 |
Why?
|
Fibula | 1 | 2021 | 266 | 0.160 |
Why?
|
Anticoagulants | 1 | 2013 | 4795 | 0.150 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 305 | 0.140 |
Why?
|
Thyroid Nodule | 1 | 2024 | 764 | 0.140 |
Why?
|
Neoplasms | 2 | 2023 | 22125 | 0.140 |
Why?
|
Liver Neoplasms | 2 | 2023 | 4308 | 0.130 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2020 | 682 | 0.130 |
Why?
|
Middle Aged | 13 | 2024 | 220835 | 0.120 |
Why?
|
Femur | 1 | 2021 | 1308 | 0.120 |
Why?
|
Adult | 11 | 2024 | 221083 | 0.120 |
Why?
|
Aged, 80 and over | 6 | 2024 | 58946 | 0.110 |
Why?
|
Aged | 10 | 2024 | 169266 | 0.100 |
Why?
|
Sensitivity and Specificity | 2 | 2024 | 14676 | 0.100 |
Why?
|
Humans | 23 | 2024 | 761098 | 0.100 |
Why?
|
Aryldialkylphosphatase | 1 | 2011 | 64 | 0.100 |
Why?
|
Male | 15 | 2024 | 360675 | 0.090 |
Why?
|
Female | 14 | 2024 | 392458 | 0.090 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2293 | 0.090 |
Why?
|
Repressor Proteins | 1 | 2021 | 2974 | 0.090 |
Why?
|
Carcinoma | 1 | 2021 | 2328 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2024 | 3163 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5300 | 0.080 |
Why?
|
Genetic Variation | 2 | 2015 | 6565 | 0.080 |
Why?
|
Kidney Neoplasms | 1 | 2024 | 4251 | 0.070 |
Why?
|
Mutation | 4 | 2024 | 30006 | 0.070 |
Why?
|
Young Adult | 5 | 2024 | 59199 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2024 | 80673 | 0.070 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1745 | 0.060 |
Why?
|
Databases, Factual | 1 | 2021 | 7969 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5318 | 0.060 |
Why?
|
Warfarin | 1 | 2013 | 1482 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15308 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5694 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12975 | 0.060 |
Why?
|
Giant Cells | 1 | 2024 | 188 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2023 | 5809 | 0.060 |
Why?
|
Lipid Peroxides | 1 | 2023 | 74 | 0.060 |
Why?
|
Cell Movement | 1 | 2015 | 5195 | 0.050 |
Why?
|
Oxyphil Cells | 1 | 2023 | 56 | 0.050 |
Why?
|
Fermentation | 1 | 2023 | 142 | 0.050 |
Why?
|
Angiomyolipoma | 1 | 2024 | 188 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2731 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 517 | 0.050 |
Why?
|
Cytodiagnosis | 1 | 2024 | 447 | 0.040 |
Why?
|
Epithelioid Cells | 1 | 2020 | 60 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9278 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2023 | 1030 | 0.040 |
Why?
|
Biopsy, Fine-Needle | 1 | 2024 | 1118 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1696 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2023 | 865 | 0.040 |
Why?
|
Child | 2 | 2024 | 80134 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11856 | 0.040 |
Why?
|
Thyroid Gland | 1 | 2023 | 1170 | 0.030 |
Why?
|
Cell Nucleus | 1 | 2024 | 2881 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17889 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2023 | 2054 | 0.030 |
Why?
|
Prognosis | 2 | 2024 | 29672 | 0.030 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 2413 | 0.020 |
Why?
|
Adolescent | 3 | 2024 | 88271 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2013 | 64670 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3149 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7844 | 0.020 |
Why?
|
Genomics | 1 | 2023 | 5828 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3881 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2021 | 5781 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13506 | 0.020 |
Why?
|
Neurons | 1 | 2023 | 9435 | 0.010 |
Why?
|
Transcription Factors | 1 | 2021 | 12096 | 0.010 |
Why?
|
Child, Preschool | 1 | 2021 | 42217 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12727 | 0.010 |
Why?
|
Mice | 1 | 2023 | 81324 | 0.010 |
Why?
|
Animals | 1 | 2023 | 168083 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2011 | 39121 | 0.010 |
Why?
|
Cohort Studies | 1 | 2011 | 41486 | 0.000 |
Why?
|